ABSTRACT: TAR DNA-binding protein of 43 kDa (TDP-43) forms granulo-filamentous aggregates in affected brain regions of >95% of patients with ALS and ∼50% of patients with frontotemporal degeneration (FTD). Furthermore, in disease, TDP-43 becomes Nterminally truncated resulting in protein deposits that are mainly composed of the C-terminal prion-like domain (PrLD). The PrLD is inherently aggregation-prone and is hypothesized to drive protein aggregation of TDP-43 in disease. Here, we establish that the N-terminal region of the protein is critical for rapid TDP-43 granulofilamentous aggregation. We show that the biopolymer poly(ADP-ribose), or PAR, inhibits granulo-filamentous aggregation of TDP-43 by engaging PAR-binding motifs (PBMs) embedded in the TDP-43 nuclear-localization sequence. We demonstrate that progressive N-terminal truncation of TDP-43 can decelerate aggregation kinetics and promote formation of thread-like filaments. Thus, the N-terminal region and the PBMs of TDP-43 promote rapid granulo-filamentous aggregation and antagonize formation of thread-like fibrils. These findings illustrate the complexity of TDP-43 aggregation trajectories.
A myotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) are two fatal neurodegenerative disorders characterized by the presence of insoluble aggregates of TAR DNAbinding protein of 43 kDa (TDP-43) in affected brain regions. 1, 2 To date, most of the disease-causing mutations in TDP-43 occur in the C-terminal prion-like domain (PrLD). 3 PrLDs are intrinsically disordered regions that can switch from unfolded states to self-templating fibril forms such as the amyloid-like cross-β fibrils.
3−7 The majority of TDP-43 aggregates in ALS/FTLD-U patients have the appearance of granular filaments, but a subset have amyloid-like qualities. 8−11 Full-length TDP-43 forms granulo-filamentous aggregates in vitro that can transition into thread-like fibrils. 4, 12, 13 This transition is promoted by certain disease-linked mutations in the PrLD, including Q331K. 12 An emerging hypothesis is that the PrLD of TDP-43 may drive the protein aggregation observed in disease. 12 PrLDs have also been implicated in liquid−liquid phase separation (LLPS), a process by which proteins condense into reversible liquid droplets. 14−16 Of interest are the ALS-linked proteins hnRNPA1, FUS, and TDP-43 which undergo LLPS in vitro. 4,16−20 We uncovered that the biopolymer poly(ADPribose) (PAR) potently promotes TDP-43 LLPS in vitro 20 and that PAR is elevated in ALS motor neuron nuclei. 21 PAR is generated by poly(ADP-ribose) polymerases (PARPs), 22 and inhibitors of various PARPs (PARP-1, PARP-2, PARP-5a, and PARP-5b) mitigate cytoplasmic aggregation of TDP-43 and TDP-43-associated toxicity to primary neurons and in Drosophila. 20, 21 These findings raised the possibility that PAR may directly regulate TDP-43 aggregation.
To determine if PAR could impact TDP-43 aggregation, we purified full-length human TDP-43 with a His 6 -SUMO solubility tag 23 ( Figures S1A and S2A ). At physiological concentrations of TDP-43 protein, 24 cleavage of the His 6 -SUMO tag with ubiquitin-like specific protease (Ulp1) induced TDP-43 aggregation over a 200 min period ( Figure  1A ). The addition of PAR to His 6 -SUMO-TDP-43-WT significantly reduced TDP-43-WT aggregation ( Figure 1A , Figure S2B ,C), while mono(ADP-ribose) had no effect ( Figure  1B ). Our previous studies established that LLPS of TDP-43 can occur in the presence of a crowding reagent and is promoted by PAR. 20 We examined TDP-43-WT by differential interference contrast (DIC) microscopy; before cleavage with and without PAR, the protein remained diffuse and did not form any visible micron-sized aggregates ( Figure S3A ). However, 30 min after Ulp-1 cleavage, we observed the formation of spherical droplets that appeared to coalesce into solid structures after a further 30 min ( Figure S3B ). Our present data indicate that under conditions that lack a crowding reagent, PAR reduces filamentous aggregation of TDP-43.
The nuclear-localization sequence (NLS) of TDP-43 is a region of intrinsic disorder 25 ( Figure S1B ) and is critical for physically binding to PAR and as well as LLPS of TDP-43 in vitro. 20 In contrast to cleaved His 6 -SUMO-TDP-43-WT, cleaved His 6 -SUMO-TDP-43-ΔPAR-binding motif (PBM) ( Figure S4A ) exhibited decelerated aggregation kinetics ( Figure 2A ) and took over 18 h to aggregate ( Figure 2B ).
The addition of PAR had no effect on the aggregation of TDP-43-ΔPBM ( Figure 2B and Figure S4B ). Examination of TDP-43-ΔPBM before cleavage revealed no preformed micron-sized aggregates ( Figure S3A ). Thus, the N-terminal region of TDP-43, and specifically the PBMs, enables rapid aggregation of TDP-43, and PAR engages PBMs within the NLS to reduce TDP-43 aggregation.
Transmission electron microscopy (TEM) revealed that cleavage of the His 6 -SUMO tag from both TDP-43-WT and TDP-43-ΔPBM led to the formation of granulo-filamentous aggregates ( Figure 3A ), consistent with previous TEM studies and of TDP-43 aggregates in human tissue. 8, 10, 12 PAR did not drastically alter the structure of the TDP-43-WT or TDP-43-ΔPBM aggregates ( Figure 3A) . However, PAR significantly reduced the overall size of the TDP-43-WT aggregates, while having no effect on the size of the TDP-43-ΔPBM aggregates ( Figure 3B ). Indeed, PAR promoted retention of TDP-43-WT in the supernatant fraction after low-speed centrifugation ( Figure 3C and Figure S5 ). Thus, we propose that PAR reduces granulo-filamentous aggregation of TDP-43 via an interaction with PBMs embedded within the NLS.
In ALS and FTLD-U, splicing defects and proteolytic cleavage can elicit formation of TDP-43 C-terminal fragments that contain the PrLD. 26−28 As the C-terminal fragments of TDP-43 either contain a partial PAR-binding region (TDP-43-C35) or lack the PAR-binding region (TDP-43-C25) ( Figure  S1A ), we examined the aggregation kinetics of these two Cterminal fragments. Strikingly, the ability of TDP-43-C35 and TDP-43-C25 to form turbid aggregates was, like TDP-43-ΔPBM, reduced compared to TDP-43-WT ( Figure 4A ). Examination by TEM revealed that TDP-43-C35 formed granulo-filamentous aggregates, whereas TDP-43-C25 formed granulo-filamentous aggregates and thread-like fibrils ( Figure  4B ). The TDP-43-C25 aggregates were unreactive to the amyloid diagnostic dye Thioflavin T ( Figure S6 ). Combined, these data reveal that the N-terminal portion of TDP-43 contributes to granulo-filamentous aggregation and antagonizes the transition into thread-like oligomers.
Here, we show that N-terminal portions of TDP-43 contribute to granulo-filamentous aggregation. Our data indicate that PAR interacts with PBMs embedded within the NLS of TDP-43 to reduce granulo-filamentous aggregation. Defining the mechanism by which PAR binding reduces TDP-43 aggregation will require further study. Regions within the N-terminal domain of TDP-43 regulate self-oligomerization. 25,29−32 Thus, PAR-binding to the NLS adjacent to the N-terminal domain may physically block interactions that contribute toward aggregation. In disease, TDP-43 aggregates appear to be predominantly granulo-filamentous. Thus, agents that antagonize contributions from the N-terminal region of TDP-43 could have therapeutic utility. However, as oligomerization is essential for TDP-43 function, 25,29−32 agents that prevent this functional oligomerization could be detrimental. Understanding under what circumstances functional versus toxic TDP-43 assemblies form, 33 how they differ, and how they are resolved will help develop therapeutic strategies to selectively target toxic assemblies.
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